Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery.
Int J Surg. 2022 Nov;107:106936. doi: 10.1016/j.ijsu.2022.106936. Epub 2022 Sep 20.
Int J Surg. 2022.
PMID: 36341760
Free article.